Everand Logo

Welcome to Everand!

  • STAT

    LISTEN: Founders’ funds, doctors’ disclosures, and the subtle art of beeping

    Is biotech too founder-friendly? Is honesty overrated? And how do you tell a good beep from a bad one? Find out on the latest episode of our biotech podcast, "The…
    by Damian Garde Sep 13, 2018 1 minute

    Is biotech too founder-friendly? Is honesty overrated? And how do you tell a good beep from a bad one?

    We discuss all that

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
    New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A Roche Obesity Drug, An Experimental Lilly Insulin, And More
    Roche disclosed that its recently acquired experimental obesity medication helped people lose a significant amount of weight in a Phase 1 trial.
    STAT2 min readChemistry
    STAT+: Pharmalittle: We’re Reading About Fake Studies, AbbVie Investing In Psychedelics, And More
    Fake studies have flooded publishers of top scientific journals,. leading to thousands of retractions and millions of dollars in lost revenue.

    Related Books & Audiobooks